Grandfield & Dodd LLC Purchases New Position in Nutrien Ltd. $NTR

Grandfield & Dodd LLC bought a new position in shares of Nutrien Ltd. (NYSE:NTRFree Report) during the second quarter, Holdings Channel.com reports. The firm bought 30,960 shares of the company’s stock, valued at approximately $1,949,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. TD Waterhouse Canada Inc. grew its stake in shares of Nutrien by 4.2% in the 4th quarter. TD Waterhouse Canada Inc. now owns 2,359,022 shares of the company’s stock worth $145,257,000 after buying an additional 94,510 shares during the last quarter. CORDA Investment Management LLC. bought a new stake in Nutrien in the 2nd quarter worth about $33,209,000. Vanguard Group Inc. grew its stake in shares of Nutrien by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 22,463,277 shares of the company’s stock worth $1,386,546,000 after acquiring an additional 479,834 shares during the period. Bryn Mawr Trust Advisors LLC bought a new stake in Nutrien in the 2nd quarter worth approximately $8,363,000. Finally, Geode Capital Management LLC grew its holdings in shares of Nutrien by 6.8% in the fourth quarter. Geode Capital Management LLC now owns 4,833,284 shares of the company’s stock worth $304,217,000 after acquiring an additional 309,025 shares during the period. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Stock Up 0.1%

Shares of NYSE:NTR opened at $68.33 on Tuesday. Nutrien Ltd. has a 1 year low of $53.03 and a 1 year high of $85.36. The business has a 50 day simple moving average of $65.94 and a two-hundred day simple moving average of $70.37. The firm has a market capitalization of $32.69 billion, a PE ratio of 13.83, a price-to-earnings-growth ratio of 0.68 and a beta of 0.61. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.39 and a quick ratio of 0.86.

Nutrien (NYSE:NTRGet Free Report) last released its earnings results on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The business had revenue of $10.81 billion for the quarter, compared to the consensus estimate of $10.44 billion. During the same period in the prior year, the company posted $2.65 EPS. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. On average, equities analysts predict that Nutrien Ltd. will post 5.01 EPS for the current year.

Nutrien Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be issued a $0.55 dividend. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.2%. Nutrien’s dividend payout ratio is presently 44.53%.

Analyst Ratings Changes

Several brokerages recently issued reports on NTR. UBS Group cut their target price on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, May 11th. Weiss Ratings raised Nutrien from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 6th. Raymond James Financial upgraded shares of Nutrien from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $74.00 to $90.00 in a report on Tuesday, May 5th. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Nutrien in a report on Monday, August 10th. Finally, BNP Paribas Exane raised shares of Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 price target for the company in a report on Tuesday, July 28th. Seventeen equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Nutrien currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.58.

Get Our Latest Analysis on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Recommended Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.